Insider · CIK 0001262325
AGUIAR ERIC
Reports to the SEC for 9 companies · PALO ALTO, CA
Transactions
50
Companies
9
Filings
14
CIK
0001262325
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-06-22 | BBIOBridgeBio Pharma, Inc.A Award | — |
| 2026-06-22 | BBIOBridgeBio Pharma, Inc. · Stock Option (Right to Buy)A Award | — |
| 2026-06-10 | BMEABiomea Fusion, Inc. · Stock Option (Right to Buy)A Award | — |
| 2025-06-20 | BBIOBridgeBio Pharma, Inc. · Stock Option (Right to Buy)A Award | — |
| 2025-06-20 | BBIOBridgeBio Pharma, Inc.A Award | — |
| 2025-06-11 | BMEABiomea Fusion, Inc. · Stock Option (Right to Buy)A Award | — |
| 2024-06-21 | BBIOBridgeBio Pharma, Inc. · Stock Option (Right to Buy)A Award | — |
| 2024-06-12 | BMEABiomea Fusion, Inc. · Stock Option (Right to Buy)A Award | — |
| 2023-06-21 | BBIOBridgeBio Pharma, Inc. · Stock Option (right to buy)A Award | — |
| 2023-06-14 | BMEABiomea Fusion, Inc. · Stock Option (Right to Buy)A Award | — |
| 2023-04-27 | Invitae CorpA Award | — |
| 2023-04-27 | Invitae CorpStock Option (right to buy)A Award | — |
| 2022-06-22 | BMEABiomea Fusion, Inc. · Stock Option (Right to Buy)A Award | — |
| 2022-06-22 | BBIOBridgeBio Pharma, Inc. · Stock Option (right to buy)A Award | — |
| 2022-04-28 | Invitae CorpA Award | — |
| 2022-04-28 | Invitae CorpStock Option (right to buy)A Award | — |
| 2022-04-28 | Invitae CorpStock Option (right to buy)A Award | — |
| 2022-04-28 | Invitae CorpA Award | — |
| 2021-06-17 | BBIOBridgeBio Pharma, Inc. · Stock Option (right to buy)A Award | — |
| 2021-04-30 | Invitae CorpStock Option (right to buy)A Award | — |
| 2021-04-30 | Invitae CorpStock Option (right to buy)A Award | — |
| 2021-04-30 | Invitae CorpA Award | — |
| 2021-04-30 | Invitae CorpA Award | — |
| 2021-04-15 | BMEABiomea Fusion, Inc. · Stock Option (Right to Buy)A Award | — |
| 2020-12-16 | Invitae CorpS Sale | −$185K |
| 2020-12-16 | Invitae CorpS Sale | −$325K |
| 2020-12-16 | Invitae CorpM Exercise/Conversion | +$242K |
| 2020-11-16 | Invitae CorpM Exercise/Conversion | +$85.1K |
| 2020-11-16 | Invitae CorpStock Option (right to buy)M Exercise/Conversion | — |
| 2020-11-16 | Invitae CorpM Exercise/Conversion | +$111K |
| 2020-11-16 | Invitae CorpStock Option (right to buy)M Exercise/Conversion | — |
| 2020-11-16 | Invitae CorpS Sale | −$1.06M |
| 2020-11-16 | Invitae CorpM Exercise/Conversion | +$91.8K |
| 2020-11-16 | Invitae CorpStock Option (right to buy)M Exercise/Conversion | — |
| 2020-11-16 | Invitae CorpS Sale | −$335K |
| 2020-07-15 | Invitae CorpS Sale | −$106K |
| 2020-07-15 | Invitae CorpStock Option (right to buy)M Exercise/Conversion | — |
| 2020-07-15 | Invitae CorpS Sale | −$234K |
| 2020-07-15 | Invitae CorpM Exercise/Conversion | +$80.8K |
| 2020-06-02 | BBIOBridgeBio Pharma, Inc. · Stock Option (right to buy)A Award | — |
| 2020-05-27 | Eidos Therapeutics, Inc.Stock Option (right to buy)A Award | — |
| 2020-05-02 | Invitae CorpStock Option (right to buy)M Exercise/Conversion | — |
| 2020-04-30 | Invitae CorpStock Option (right to buy)A Award | — |
| 2020-01-22 | Biohaven Pharmaceutical Holding Co Ltd.S Sale | −$11.6K |
| 2020-01-22 | Biohaven Pharmaceutical Holding Co Ltd.S Sale | −$38.2K |
| 2020-01-22 | Biohaven Pharmaceutical Holding Co Ltd.S Sale | −$28K |
| 2020-01-22 | Biohaven Pharmaceutical Holding Co Ltd.S Sale | −$27.5K |
| 2020-01-22 | Biohaven Pharmaceutical Holding Co Ltd.M Exercise/Conversion | +$46.9K |
| 2020-01-22 | Biohaven Pharmaceutical Holding Co Ltd.M Exercise/Conversion | +$25K |
| 2020-01-22 | Biohaven Pharmaceutical Holding Co Ltd.Employee Stock Option (Right to Buy)M Exercise/Conversion | — |
Recent filings
- 4AGUIAR ERIC0001470831-26-000632SEC(opens sec.gov)
- 4AGUIAR ERIC0001193125-26-269469SEC(opens sec.gov)
- 4AGUIAR ERIC0000950170-25-089667SEC(opens sec.gov)
- 4AGUIAR ERIC0000950170-25-086191SEC(opens sec.gov)
- 4AGUIAR ERIC0000950170-24-077437SEC(opens sec.gov)
- 4AGUIAR ERIC0000950170-24-073068SEC(opens sec.gov)
- 4AGUIAR ERIC0001209191-23-039342SEC(opens sec.gov)
- 4AGUIAR ERIC0000950170-23-028668SEC(opens sec.gov)
- 4AGUIAR ERIC0000899243-23-011928SEC(opens sec.gov)
- 4AGUIAR ERIC0000899243-22-024053SEC(opens sec.gov)
- 4AGUIAR ERIC0001209191-22-039225SEC(opens sec.gov)
- 4AGUIAR ERIC0000899243-22-016133SEC(opens sec.gov)
- 4AGUIAR ERIC0000899243-21-025359SEC(opens sec.gov)
- 4AGUIAR ERIC0000899243-21-018203SEC(opens sec.gov)
Companies
- Biohaven Pharmaceutical Holding Co Ltd.Director
- Biomea Fusion, Inc.DirectorBMEA
- BridgeBio Pharma, Inc.DirectorBBIO
- Cardiovascular Systems Inc10% Owner
- CORNERSTONE THERAPEUTICS INC10% Owner
- Eidos Therapeutics, Inc.Director
- Invitae CorpDirector
- MiddleBrook Pharmaceuticals, Inc.10% Owner
- Ocera Therapeutics, Inc.10% Owner
Address
C/O BRIDGEBIO PHARMA, INC. 3160 PORTER DR., SUITE 250
PALO ALTO, CA, 94304